|
Volumn 254, Issue 24, 1985, Pages 3461-3463
|
Adjuvant Chemotherapy for Breast Cancer
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TAMOXIFEN;
CYCLOPHOSPHAMIDE;
CYTOSTATIC AGENT;
ESTROGEN RECEPTOR;
PREDNISONE;
STEROID;
ADULT;
ARTICLE;
AXILLA;
BREAST TUMOR;
FEMALE;
HEALTH CARE ORGANIZATION;
HUMAN;
LYMPH NODE METASTASIS;
MENOPAUSE;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
OVARIECTOMY;
PRACTICE GUIDELINE;
TUMOR RECURRENCE;
UNITED STATES;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADVERSE DRUG REACTION;
BLOOD AND HEMOPOIETIC SYSTEM;
BONE MARROW DEPRESSION;
BREAST;
BREAST CANCER;
CANCER CHEMOTHERAPY;
DIGESTIVE SYSTEM;
DRUG THERAPY;
EDITORIAL;
ENDOCRINE SYSTEM;
GASTROINTESTINAL SYMPTOM;
HAIR LOSS;
HORMONAL THERAPY;
LYMPHATIC SYSTEM;
POSTMENOPAUSE;
PREMENOPAUSE;
PRIORITY JOURNAL;
THERAPY;
ANTINEOPLASTIC AGENTS;
AXILLA;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMAN;
LYMPHATIC METASTASIS;
MENOPAUSE;
MIDDLE AGE;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASM RECURRENCE, LOCAL;
OVARIECTOMY;
TAMOXIFEN;
UNITED STATES;
|
EID: 0022338828
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.1985.03360240073038 Document Type: Article |
Times cited : (233)
|
References (0)
|